Thomas  Tu net worth and biography

Thomas Tu Biography and Net Worth

Insider of Inari Medical
Dr. Thomas Tu joins Inari Medical after practicing Interventional Cardiology for 16 years. He is a graduate of Harvard Medical School and completed residency at Massachusetts General Hospital. He was trained in Interventional Cardiology, Peripheral Vascular Intervention, and Structural Heart Disease at Beth Israel Deaconess Medical Center. Most recently, he was the Cath Lab director and leader of the Pulmonary Embolism, complex PCI, and TAVR programs at Baptist Health Louisville. Dr. Tu helped develop the early phase technology that allowed Inari Medical to optimize patient outcomes. He also served as the presenter for the FLARE IDE trial of the Inari FlowTriever Retrieval/Aspiration System. This study led to FDA 510 (k) clearance for treatment of pulmonary embolism, the first thrombectomy device cleared for that indication.

What is Thomas Tu's net worth?

The estimated net worth of Thomas Tu is at least $16.14 million as of July 15th, 2024. Dr. Tu owns 313,257 shares of Inari Medical stock worth more than $16,139,001 as of December 3rd. This net worth evaluation does not reflect any other assets that Dr. Tu may own. Additionally, Dr. Tu receives a salary of $865,630.00 as Insider at Inari Medical. Learn More about Thomas Tu's net worth.

How old is Thomas Tu?

Dr. Tu is currently 51 years old. There are 1 older executives and no younger executives at Inari Medical. The oldest executive at Inari Medical is Mr. Paul A. Koehn, Senior Vice President of Operations, who is 61 years old. Learn More on Thomas Tu's age.

What is Thomas Tu's salary?

As the Insider of Inari Medical, Inc., Dr. Tu earns $865,630.00 per year. The highest earning executive at Inari Medical is Mr. Andrew J. Hykes, CEO, President & Director, who commands a salary of $1,540,000.00 per year. Learn More on Thomas Tu's salary.

How do I contact Thomas Tu?

The corporate mailing address for Dr. Tu and other Inari Medical executives is 9 Parker Suite 100, Irvine CA, 92618. Inari Medical can also be reached via phone at 877-923-4747 and via email at [email protected]. Learn More on Thomas Tu's contact information.

Has Thomas Tu been buying or selling shares of Inari Medical?

Thomas Tu has not been actively trading shares of Inari Medical in the last ninety days. Most recently, Thomas Tu sold 16,520 shares of the business's stock in a transaction on Monday, July 15th. The shares were sold at an average price of $55.09, for a transaction totalling $910,086.80. Following the completion of the sale, the insider now directly owns 313,257 shares of the company's stock, valued at $17,257,328.13. Learn More on Thomas Tu's trading history.

Who are Inari Medical's active insiders?

Inari Medical's insider roster includes Rebecca Chambers (Director), Mitch Hill (CFO), William Hoffman (CEO), Andrew Hykes (CEO, President & Director), Donald Milder (Director), Kirk Nielsen (Director), and Thomas Tu (Insider). Learn More on Inari Medical's active insiders.

Are insiders buying or selling shares of Inari Medical?

In the last year, insiders at the sold shares 26 times. They sold a total of 531,244 shares worth more than $26,328,373.16. The most recent insider tranaction occured on November, 18th when Director William Hoffman sold 60,000 shares worth more than $3,069,600.00. Insiders at Inari Medical own 10.6% of the company. Learn More about insider trades at Inari Medical.

Information on this page was last updated on 11/18/2024.

Thomas Tu Insider Trading History at Inari Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/15/2024Sell16,520$55.09$910,086.80313,257View SEC Filing Icon  
11/16/2023Sell25,451$59.82$1,522,478.82320,932View SEC Filing Icon  
8/16/2023Sell24,926$66.11$1,647,857.86347,997View SEC Filing Icon  
5/16/2023Sell12,176$70.87$862,913.12386,478View SEC Filing Icon  
2/27/2023Sell10,000$56.72$567,200.00107,112View SEC Filing Icon  
1/27/2023Sell10,000$60.69$606,900.0085,700View SEC Filing Icon  
12/27/2022Sell10,000$63.29$632,900.0086,451View SEC Filing Icon  
11/28/2022Sell10,000$74.86$748,600.0086,451View SEC Filing Icon  
10/27/2022Sell10,000$75.02$750,200.0096,451View SEC Filing Icon  
3/28/2022Sell2,000$90.00$180,000.00View SEC Filing Icon  
3/1/2022Sell2$90.00$180.00View SEC Filing Icon  
11/29/2021Sell5,000$83.40$417,000.00View SEC Filing Icon  
10/27/2021Sell5,000$87.68$438,400.00View SEC Filing Icon  
9/27/2021Sell5,000$82.86$414,300.00View SEC Filing Icon  
8/27/2021Sell5,000$81.31$406,550.00View SEC Filing Icon  
7/27/2021Sell5,000$84.20$421,000.00View SEC Filing Icon  
6/28/2021Sell5,000$95.94$479,700.0054,092View SEC Filing Icon  
5/27/2021Sell5,000$88.32$441,600.0054,092View SEC Filing Icon  
4/27/2021Sell5,000$113.12$565,600.0044,092View SEC Filing Icon  
3/26/2021Sell5,000$103.31$516,550.0044,344View SEC Filing Icon  
2/26/2021Sell5,000$103.76$518,800.00View SEC Filing Icon  
1/27/2021Sell5,000$98.49$492,450.0033,091View SEC Filing Icon  
1/20/2021Sell12,000$100.42$1,205,040.0040,091View SEC Filing Icon  
12/21/2020Sell1,500$74.00$111,000.0029,591View SEC Filing Icon  
11/30/2020Sell3,500$67.72$237,020.0031,591View SEC Filing Icon  
See Full Table

Thomas Tu Buying and Selling Activity at Inari Medical

This chart shows Thomas Tu's buying and selling at Inari Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inari Medical Company Overview

Inari Medical logo
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $51.55
Low: $50.40
High: $52.00

50 Day Range

MA: $46.67
Low: $40.62
High: $53.35

2 Week Range

Now: $51.55
Low: $36.73
High: $67.13

Volume

494,939 shs

Average Volume

977,895 shs

Market Capitalization

$3.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97